Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Santhera Pharmaceuticals Holding AG    SANN   CH0027148649

SANTHERA PHARMACEUTICALS HOLDING AG

(SANN)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
02/11/2019 02/12/2019 02/13/2019 02/14/2019 02/15/2019 Date
5.69(c) 5.83(c) 5.8(c) 5.8(c) 5.99(c) Last
21 478 13 531 33 392 24 528 31 501 Volume
-3.56% +2.46% -0.51% 0.00% +3.28% Change
More quotes
Financials (CHF)
Sales 2018 30,8 M
EBIT 2018 -50,4 M
Net income 2018 -40,0 M
Finance 2018 1,56 M
Yield 2018 -
Sales 2019 36,1 M
EBIT 2019 -37,6 M
Net income 2019 -23,0 M
Finance 2019 32,2 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 2,02x
EV / Sales2019 0,88x
Capitalization 63,9 M
More Financials
Company
Santhera Pharmaceuticals Holding AG (Santhera) is a Switzerland-based company engaged in the pharmaceutical sector. The Company is involved in the research, development and commercialization of pharmaceutical products for the treatment of neuromuscular and mitochondrial diseases. The Company’s... 
Sector
Pharmaceuticals
Calendar
02/15Presentation
More about the company
Surperformance© ratings of Santhera Pharmaceuticals H
Trading Rating : - Investor Rating :
More Ratings
Latest news on SANTHERA PHARMACEUTICALS H
2018SANTHERA PHARMACEUTICALS : Raises Gross Proceeds of CHF 23.5 Million and Secures..
GL
2018SANTHERA PHARMACEUTICALS : Provides Update on the Share Placement
GL
2018SANTHERA PHARMACEUTICALS : Announces Financial Results for the First Nine Months..
GL
2018SANTHERA PHARMACEUTICALS : Launches Placement of Shares through Accelerated Book..
GL
2018SANTHERA PHARMACEUTICALS : Extraordinary General Meeting Approves Capital Increa..
PU
2018SANTHERA PHARMACEUTICALS : Extraordinary General Meeting Approves Capital Increa..
GL
2018SANTHERA PHARMACEUTICALS : Board of Directors Submits Amended Proposal to its Ex..
PU
2018Deal with Idorsia gives Santhera shot at second DMD candidate
AQ
2018SANTHERA PHARMACEUTICALS : Calls Extraordinary General Meeting and Proposes Ordi..
GL
2018IDORSIA : Santhera Enters into Agreement to Acquire Option from Idorsia for Excl..
AQ
More news
Analyst Recommendations on SANTHERA PHARMACEUTICALS H
More recommendations
Sector news : Specialty & Advanced Pharmaceuticals
02/15BRISTOL MYERS SQUIBB : Starboard gauges Bristol-Myers shareholder support for Ce..
RE
02/15Bayer gains full Vitrakvi rights from Eli Lilly's Loxo
RE
02/15WSJ TAX GUIDE 2019 : What Investors Need to Know -2-
DJ
02/15WSJ TAX GUIDE 2019 : What Investors Need to Know -- Journal Report
DJ
02/15WSJ TAX GUIDE 2019 : The Drug Industry -- Journal Report
DJ
More sector news : Specialty & Advanced Pharmaceuticals
Chart SANTHERA PHARMACEUTICALS HOLDING AG
Duration : Period :
Santhera Pharmaceuticals Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANTHERA PHARMACEUTICALS H
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 5,00  CHF
Spread / Average Target -17%
EPS Revisions
Managers
NameTitle
Thomas Meier Chief Executive Officer & Director
Elmar J. Schnee Chairman
Christoph Rentsch Chief Financial Officer
Kristina Sjöblom Nygren Chief Medical Officer, EVP & Head-Development
Kristina Sjoblom Nygren Chief Medical Officer & Head-Development
Sector and Competitors
1st jan.Capitalization (M$)
SANTHERA PHARMACEUTICALS HOLDING AG-11.13%64
ABBVIE-12.30%121 616
MERCK KGAA7.71%14 147
KYOWA HAKKO KIRIN CO LTD5.23%11 129
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD13.36%8 757
JAZZ PHARMACEUTICALS PLC1.10%7 596